NOGO-A in Multiple Sclerosis FTIH

NCT01424423 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

3

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Sclerosis

Interventions

DRUG: Placebo
DRUG: GSK1223249

Sponsor

GlaxoSmithKline